RGC — Regencell Bioscience Holdings Limited (Stock)

Price: $5.98 · 1 day: -4.01% · 5 days: +5.28% · 1 month: +13.04% · YTD: -71.52%
As of 2026-09-23 20:00 UTC.

52-week range: $4.51 – $69.0 (currently at 2% of the range).

The read

RGC is in a turning down, momentum firm. $6 is the level overhead; $5.68 the first support below.

3 of 6 technical checks lean mixed.

• Price vs 50-day: above
• Price vs 200-day: below
• 50d vs 200d avg: below
• MACD: bullish
• RSI momentum: 45
• 5-day tape: +5.3%

Key levels

Indicators

Next earnings: 2026-10-28.

Latest RGC news

• California's Largest College of Education Unveils Framework for AI as a Companion to Teaching and Learning — National University's Sanford College of Education, California's largest provider of teaching credentials, has introduced RAISE 5 (Rules for AI Scholastic Engagement), a five-tier framework governing artificial intellige (PR Newswire, 2026-07-23)
• Spinogenix Announces World Health Organization Approval of "Codabakalner" as International Nonproprietary Name for SPG601 — Spinogenix announced that the World Health Organization's INN Expert Committee approved "codabakalner" as the non-proprietary name for its investigational therapy SPG601. Codabakalner is a first-in-class, oral positive m (PR Newswire, 2026-07-16)
• Elevance Stock Falls on Medicaid Concerns — Elevance Health shares declined 10% on Wednesday amid broader weakness in managed care stocks, with competitors Centene and Molina also trading lower. The sector is facing pressure from declining enrollment in Affordable (The Wall Street Journal, 2026-07-15)
• Cathay Capital Invests in Ascendia Autism Care to Expand Access to Evidence-Based ABA Therapy for Children and Families — Cathay Capital announced the launch of Ascendia Autism Care, a new platform expanding access to Applied Behavior Analysis (ABA) therapy for children with autism spectrum disorder. Ascendia begins operations with a foundi (PR Newswire, 2026-06-30)
• Bronstein, Gewirtz & Grossman LLC Urges Regencell Bioscience Holdings Ltd. Investors to Act: Class Action Filed Alleging Investor Harm — Bronstein, Gewirtz & Grossman LLC has filed a class action lawsuit against Regencell Bioscience Holdings Ltd. (NASDAQ: RGC) and certain company officers, alleging violations of federal securities laws. The lawsuit covers (PR Newswire, 2026-06-23)
• Regencell Deadline Today: Rosen Law Firm Urges Regencell Bioscience Holdings Limited (NASDAQ: RGC) Stockholders with Large Losses to Contact the Firm for Information About Their Rights — Rosen Law Firm has announced a class action lawsuit against Regencell Bioscience Holdings Limited (NASDAQ: RGC) on behalf of shareholders who purchased securities between October 28, 2024 and October 31, 2025. The lawsui (Business Wire, 2026-06-23)
• RGC Shareholder Alert: June 23, 2026 Lead Plaintiff Deadline in Regencell Bioscience Holdings Limited Securities Class Action - Contact The Gross Law Firm — The Gross Law Firm has announced a securities class action lawsuit against Regencell Bioscience Holdings Limited (NASDAQ: RGC) with a lead plaintiff deadline of June 23, 2026. The lawsuit covers the period from October 2 (PR Newswire, 2026-06-23)
• RGC FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Regencell Bioscience (RGC) Investors of Securities Class Action Lawsuit Deadline on June 23, 2026 — Faruqi & Faruqi, LLP announced a federal securities class action lawsuit against Regencell Bioscience Holdings Limited (NASDAQ: RGC) alleging that company executives made false and misleading statements by concealing the (Business Wire, 2026-06-23)

Explore more

Interactive RGC chart and analyst chat · Market terminal — movers, signals and news · Use MarketCrew inside Claude · Use MarketCrew inside ChatGPT · Top gainers today · 52-week highs